These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24244869)

  • 1. FGF2 modulates cardiac remodeling in an isoform- and sex-specific manner.
    Nusayr E; Sadideen DT; Doetschman T
    Physiol Rep; 2013 Sep; 1(4):. PubMed ID: 24244869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac development and physiology are modulated by FGF2 in an isoform- and sex-specific manner.
    Nusayr E; Doetschman T
    Physiol Rep; 2013 Sep; 1(4):. PubMed ID: 24244870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity.
    Koleini N; Santiago JJ; Nickel BE; Sequiera GL; Wang J; Fandrich RR; Jassal DS; Dhingra S; Kirshenbaum LA; Cattini PA; Kardami E
    Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H279-H288. PubMed ID: 30412444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression.
    Koleini N; Nickel BE; Nagalingam RS; Landry NM; Fandrich RR; Cheung DYC; Dixon IM; Czubryt MP; Jassal DS; Cattini PA; Kardami E
    Cell Tissue Res; 2021 Sep; 385(3):753-768. PubMed ID: 34057573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling.
    Santiago JJ; McNaughton LJ; Koleini N; Ma X; Bestvater B; Nickel BE; Fandrich RR; Wigle JT; Freed DH; Arora RC; Kardami E
    PLoS One; 2014; 9(5):e97281. PubMed ID: 24827991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition.
    Srisakuldee W; Nickel BE; Fandrich RR; Zhang F; Pasumarthi KBS; Kardami E
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling.
    Liao S; Porter D; Scott A; Newman G; Doetschman T; Schultz Jel J
    J Mol Cell Cardiol; 2007 Jan; 42(1):106-20. PubMed ID: 17150229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.
    House SL; House BE; Glascock B; Kimball T; Nusayr E; Schultz JE; Doetschman T
    Mol Cell Pharmacol; 2010; 2(4):143-154. PubMed ID: 21274419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.
    Liao S; Bodmer JR; Azhar M; Newman G; Coffin JD; Doetschman T; Schultz Jel J
    J Mol Cell Cardiol; 2010 Jun; 48(6):1245-54. PubMed ID: 20116383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High molecular weight fibroblast growth factor 2 induces apoptosis by interacting with complement component 1 Q subcomponent-binding protein in vitro.
    Hong X; Yu Z; Chen Z; Jiang H; Niu Y; Huang Z
    J Cell Biochem; 2018 Nov; 119(11):8807-8817. PubMed ID: 30159917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction.
    Manning JR; Perkins SO; Sinclair EA; Gao X; Zhang Y; Newman G; Pyle WG; Schultz Jel J
    Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1382-96. PubMed ID: 23479264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response.
    Schultz JE; Witt SA; Nieman ML; Reiser PJ; Engle SJ; Zhou M; Pawlowski SA; Lorenz JN; Kimball TR; Doetschman T
    J Clin Invest; 1999 Sep; 104(6):709-19. PubMed ID: 10491406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
    House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J
    Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
    Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
    J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
    Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
    Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of protein kinase C isoforms, as well as Akt and p70 S6 kinases. [corrected].
    Jiang ZS; Wen GB; Tang ZH; Srisakuldee W; Fandrich RR; Kardami E
    Can J Physiol Pharmacol; 2009 Oct; 87(10):798-804. PubMed ID: 19898562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.
    Liao S; Bodmer J; Pietras D; Azhar M; Doetschman T; Schultz Jel J
    Dev Dyn; 2009 Feb; 238(2):249-64. PubMed ID: 18773489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock transcription factor 1 protects against pressure overload-induced cardiac fibrosis via Smad3.
    Zhou N; Ye Y; Wang X; Ma B; Wu J; Li L; Wang L; Wang DW; Zou Y
    J Mol Med (Berl); 2017 Apr; 95(4):445-460. PubMed ID: 28091697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of STAT6 Signal Promotes Cardiac Fibrosis Through the Mobilization and Transformation of CD11b
    Zhang W; Zhu B; Ding S; Wang X; Wu J; Zhu X; Zou Y; Ge J; Tong M; Yang X
    Front Physiol; 2020; 11():579712. PubMed ID: 33192584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.